Therapeutic Potential of Medical Cannabis for Chronic Skin Inflammation
Research exploring medical cannabis and phytocannabinoid compounds for treating and preventing chronic inflammatory skin conditions such as dermatitis and psoriasis. The work investigates anti-inflammatory, hydrating, and antimicrobial properties of cannabinoids and hemp oil, with focus on how cannabis chemical phenotypes influence therapeutic outcomes.
Overview
This research investigates the therapeutic potential of medical cannabis and its key phytocannabinoid compounds for the treatment and prevention of chronic inflammatory skin conditions, including dermatitis and psoriasis. The work explores multiple mechanisms of action, including the anti-inflammatory properties of cannabinoids such as THC and CBD, the skin-hydrating effects of essential fatty acids in hemp oil, the antimicrobial properties that may combat bacterial skin infections, and the potential for phytocannabinoids to reduce stress-related dermatological triggers through nervous system relaxation. The research aims to establish scientific evidence supporting cannabis-based approaches to dermatological care.
Technical specifications
Key research areas:
- Evaluation of phytocannabinoid anti-inflammatory properties for mitigating skin inflammation
- Investigation of essential fatty acids in hemp oil for skin moisturization and barrier support
- Assessment of antimicrobial properties of cannabis compounds against bacteria associated with skin ailments
- Exploration of nervous system relaxation effects and their role in stress-related dermatological conditions
- Analysis of how chemical phenotypes, genotypes, and harvest timing influence cannabinoid and flavonoid composition
- Study of how compound variability affects the biological activity of carrier matrices used for topical skin applications
Technology readiness level
This proposal is at an early-stage hypothesis development phase. The research hypothesis is grounded in existing scientific evidence on cannabinoids and skin health, but further research and clinical studies are needed to validate the proposed therapeutic effects. Future validation will require systematic investigation of how cannabis chemical phenotypes, genotypes, and harvest time influence the composition of active compounds and the resulting biological activity in dermatological applications.
About Czech University of Life Sciences Prague
Czech University of Life Sciences Prague is a public research university on a modern green campus in Prague‑Suchdol, combining academic breadth with a strong applied, land‑based mission. University‑owned enterprises—a farm estate at Lány and a forest enterprise at Kostelec nad Černými lesy—provide real‑world testbeds, pilot plots, and production‑scale assets for trials, prototyping, and training. Industry engages through an on‑campus business incubator and a dedicated Technology Transfer Office that supports IP, licensing, proof‑of‑concept work, and collaborative R&D. A private 5G network developed with T‑Mobile enables IoT pilots across fields, forests, and facilities, while research is backed by Horizon Europe and national agencies such as the Czech Science Foundation and the Technology Agency of the Czech Republic.
Inquire about this partnering listing
Looking for
Industry applications
delivered to your inbox.